REFERENCES
- Blei F., Wilson E., Lynette M., Paolo, Rifkin D. B. Mechanism of action of angiostatic steroids: Suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J. Cell Physiol. 1993; 155: 568–578
- Bora P. S., Sohn J., Cruz J., Jha P., Nishihori H., Wang Y., Kaliappan S., Kaplan H. J., Bora N. S. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. J. Immunol. 2005; 174: 491–497
- Cardillo J. A, Farah M. E., Mitre J., Morales P. H., Costa R. A., Melo L. A. S., Kuppermann B., Jorge R., Ashton P. An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy. Br. J. Ophthalmol. 2004; 88: 1201–1205
- Cynkowska G., Cynkowski T., Al-Ghananeem A. M., Guo H., Ashton P., Crooks P. A. Novel antiglaucoma prodrugs and codrugs of ethacrynic acid. Bioorg. Med. Chem. Lett. 2005; 15: 3524–3527
- Del Nozal M. J., Bernal J. L., Pampliega A., Pastor J. C., Lopez M. I. Determination of 5-fluorouracil in vitreous gel and liquid by high-performance liquid chromatography. J. Chromatogr. 1992; 607: 183–189
- Fialho S. L., Da Silva-Cunha A. New vehicle based on a microemulsion for topical ocular administration of dexamethasone. Clin. Expt. Ophthalmol. 2004; 32: 626–32
- Frishman W. H., Kowalski M., Nagnur S., Warshafsky S., Sica D. Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: Focus on β -adrenergic blockade. Heart Dis. 2001; 3: 386–397
- Howard-Sparks M., Al-Ghananeem A. M., Pearson A. P., Crooks P. A. Evaluation of O3α -, O21-Di-(N1-methyloxycarbonyl-2, 4-dioxo-5-fluoropyrimidinyl)17α -hydroxy-5β -pregnan-20-one as a novel potential antiangiogenic codrug. J. Enzyme Inhib. Med. Chem. 2005; 20: 417–428
- Jonas J. B. Intraocular availability of triamcinolone acetonide after intravitreal injection. Am. J. Ophthalmol. 2004; 137: 560–562
- Lee P., Wang C. C., Adamis A. P. Ocular neovascularization: an epidemiological review. Surv. Ophthalmol. 1998; 43: 245–269
- Myles M. E., Neumann D. M., Hill J. M. Recent progress in ocular drug delivery for posterior segment disease : emphasis on transscleral iontophoresis. Adv. Drug Deliv. Rev. 2005; 57: 2063–2079
- Peyman G. A., Ganiban G. J. Delivery systems for intraocular routes. Adv. Drug Deliv. Rev. 1995; 16: 107–123
- Speicher M. A., Danis R. P., Criswell M., Pratt L. Pharmacologic therapy for diabetic retinopathy. Expert Opin. Emerg. Drugs. 2003; 8: 239–250